Hematopoietic Age at Onset of Triple-Negative Breast Cancer Dictates Disease Aggressiveness and Progression

These results elucidate the cellular mechanisms underlying the aggressiveness of triple-negative breast cancer in young women compared with older women, providing a rationale to investigate age-stratified therapies that in particular target the age-sensitive bone marrow microenvironment.